AC Immune (ACIU) EPS (Basic) (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,895.47% |
| Sep 30, 2025 | 25.29% |
| Jun 30, 2025 | -11.05% |
| Mar 31, 2025 | -20.27% |
| Dec 31, 2024 | -385.98% |
| Sep 30, 2024 | 124.11% |
| Jun 30, 2024 | -20.57% |
| Mar 31, 2024 | 84.76% |
| Dec 31, 2023 | -566.53% |
| Sep 30, 2023 | 10.14% |
| Jun 30, 2023 | 4.04% |
| Mar 31, 2023 | 95.66% |
| Jun 30, 2022 | -4.17% |
| Mar 31, 2022 | 95.57% |
| Dec 31, 2021 | -2,267.38% |
| Sep 30, 2021 | 19.15% |
| Jun 30, 2021 | -15.58% |
| Mar 31, 2021 | 95.77% |
| Dec 31, 2020 | -1,953.63% |
| Sep 30, 2020 | -12.77% |
| Jun 30, 2020 | -146.39% |
| Mar 31, 2020 | 98.39% |
| Dec 31, 2019 | -100.00% |
| Sep 30, 2019 | 178.49% |
| Dec 31, 2017 | 146.11% |
| Sep 30, 2017 | -9.53% |
| Jun 30, 2017 | 13.57% |
| Mar 31, 2017 | -98.05% |
| Dec 31, 2016 | -1,096.77% |
| Sep 30, 2016 | -115.15% |